D. Demarles

A Comparison of the Steady‐State Pharmacokinetics and Safety of Abacavir, Lamivudine, and Zidovudine Taken as a Triple Combination Tablet and as Abacavir plus a Lamivudine‐Zidovudine Double Combination Tablet by HIV‐1‐Infected Adults

C. Katlama, F. Raffi, A. Crémieux, 2001, Pharmacotherapy.

Single-Dose Pharmacokinetics of Amprenavir Coadministered with Grapefruit Juice

A. Taburet, I. Vincent, C. Gillotin, 2002, Antimicrobial Agents and Chemotherapy.

Steady-State Pharmacokinetics of Amprenavir Coadministered with Ritonavir in Human Immunodeficiency Virus Type 1-Infected Patients

C. Goujard, A. Taburet, J. Meynard, 2003, Antimicrobial Agents and Chemotherapy.

Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.

F. Colland, B. Davis, R. Hubbard, 2019, Journal of medicinal chemistry.

Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor.

F. Colland, R. Hubbard, M. Chanrion, 2020, Journal of medicinal chemistry.

Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors.

N. Foloppe, J. Murray, R. Hubbard, 2021, Journal of medicinal chemistry.

Structure-Guided Discovery of a Selective Mcl-1 Inhibitor with Cellular Activity.

F. Colland, B. Davis, R. Hubbard, 2019, Journal of medicinal chemistry.